iver surgery for HCC within and outside the BCLC criteria - a retrospective comparative analysis

• Conditions: C22; Malignant neoplasm of liver and intrahepatic bile ducts

• Registration Number: DRKS00028902
• Lead Sponsor: Technische Universität Dresden

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-06-15
• Study Start: 2022-06-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 165

Inclusion Criteria

All patients recorded in the liver database of the Department of Visceral, Thoracic and Vascular Surgery who underwent liver resection for therapy of HCC in the UKD (VTG) from 2013-2021.

Exclusion Criteria

does not apply

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparative subgroup analysis between patients with HCC on the ground of liver cirrhosis as well as without liver cirrhosis.

Secondary Outcome Measures

Name	Time	Method
- Analysis and presentation of patient characteristics, perioperative parameters, postoperative parameters and oncological Long-term oncologic outcomes. - Comparative analysis of postoperative outcomes with Therapy within or outside the BCLC-therapy recommendation for the entire analysis collective as well as within the subgroups with and without liver cirrhosis.- Univariate and multivariate analysis to identify risk factors for morbidity, mortality, and re-Surgery rate and long-term oncologic outcome.- Comparative analysis of the accuracy of radiological BCL classification and assessment of liver cirrhosis. regarding liver cirrhosis.